600201 生物股份
已收盘 12-05 15:00:00
资讯
新帖
简况
每周股票复盘:生物股份(600201)将召开2025年Q3业绩说明会
证券之星 · 11-23
每周股票复盘:生物股份(600201)将召开2025年Q3业绩说明会
11月13日生物股份涨9.11%,国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 11-13
11月13日生物股份涨9.11%,国泰中证畜牧养殖ETF基金重仓该股
生物股份涨9.11%,中航证券二个月前给出“买入”评级
证券之星 · 11-13
生物股份涨9.11%,中航证券二个月前给出“买入”评级
太平洋:给予生物股份买入评级
证券之星 · 11-04
太平洋:给予生物股份买入评级
每周股票复盘:生物股份(600201)Q3净利同比增116.4%
证券之星 · 11-02
每周股票复盘:生物股份(600201)Q3净利同比增116.4%
生物股份(600201)披露股份回购实施结果暨股份变动的公告,10月31日股价上涨1.31%
证券之星 · 10-31
生物股份(600201)披露股份回购实施结果暨股份变动的公告,10月31日股价上涨1.31%
生物股份(600201)2025年三季报简析:增收不增利,公司应收账款体量较大
证券之星 · 10-29
生物股份(600201)2025年三季报简析:增收不增利,公司应收账款体量较大
生物股份(600201)9月30日股东户数4.9万户,较上期减少10.7%
证券之星 · 10-27
生物股份(600201)9月30日股东户数4.9万户,较上期减少10.7%
生物股份(600201.SH)发布前三季度业绩,归母净利润1.61亿元,下降4.85%
智通财经 · 10-27
生物股份(600201.SH)发布前三季度业绩,归母净利润1.61亿元,下降4.85%
每周股票复盘:生物股份(600201)子公司获牛疫苗新兽药证
证券之星 · 10-19
每周股票复盘:生物股份(600201)子公司获牛疫苗新兽药证
生物股份(600201)披露子公司取得新兽7月16日股价下跌1.9%
证券之星 · 10-16
生物股份(600201)披露子公司取得新兽7月16日股价下跌1.9%
生物股份(600201.SH):牛产气荚膜梭菌病(A型)基因工程亚单位疫苗取得新兽药注册证书
智通财经 · 10-16
生物股份(600201.SH):牛产气荚膜梭菌病(A型)基因工程亚单位疫苗取得新兽药注册证书
每周股票复盘:生物股份(600201)累计回购1,571.33万股
证券之星 · 10-12
每周股票复盘:生物股份(600201)累计回购1,571.33万股
新开源:所持永泰生物股份占其比例为1.48%
证券之星 · 10-10
新开源:所持永泰生物股份占其比例为1.48%
生物股份(600201)披露以集中竞价交易方式回购公司股份的进展公告,10月09日股价上涨0.93%
证券之星 · 10-09
生物股份(600201)披露以集中竞价交易方式回购公司股份的进展公告,10月09日股价上涨0.93%
异动快报:生物股份(600201)9月26日11点0分触及涨停板
证券之星 · 09-26
异动快报:生物股份(600201)9月26日11点0分触及涨停板
每周股票复盘:生物股份(600201)将召开2025年半年度业绩说明会
证券之星 · 09-21
每周股票复盘:生物股份(600201)将召开2025年半年度业绩说明会
生物股份(600201)披露召开2025年半年度业绩说明会公告,9月15日股价上涨7.17%
证券之星 · 09-15
生物股份(600201)披露召开2025年半年度业绩说明会公告,9月15日股价上涨7.17%
9月15日生物股份涨7.17%,国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 09-15
9月15日生物股份涨7.17%,国泰中证畜牧养殖ETF基金重仓该股
生物股份涨7.17%,中航证券三周前给出“买入”评级
证券之星 · 09-15
生物股份涨7.17%,中航证券三周前给出“买入”评级
加载更多
公司概况
公司名称:
金宇生物技术股份有限公司
所属行业:
医药制造业
上市日期:
1999-01-15
主营业务:
金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。
发行价格:
6.83
{"stockData":{"symbol":"600201","market":"SH","secType":"STK","nameCN":"生物股份","latestPrice":13.4,"timestamp":1764918000000,"preClose":13,"halted":0,"volume":50213492,"delay":0,"changeRate":0.0308,"floatShares":1112000000,"shares":1112000000,"eps":0.0907,"marketStatus":"已收盘","change":0.4,"latestTime":"12-05 15:00:00","open":12.99,"high":13.57,"low":12.71,"amount":667000000,"amplitude":0.0662,"askPrice":13.4,"askSize":1530,"bidPrice":13.39,"bidSize":473,"shortable":0,"etf":0,"ttmEps":0.0907,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":13,"symbolType":"stock","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":14.3,"lowLimit":11.7,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1111747826,"isCdr":false,"pbRate":2.72,"roa":"--","peRate":147.739802,"roe":"3.0%","epsLYR":0.1,"committee":0.09045,"marketValue":14897000000,"turnoverRate":0.0452,"status":0,"floatMarketCap":14897000000},"requestUrl":"/m/hq/s/600201","defaultTab":"news","newsList":[{"id":"2585103541","title":"每周股票复盘:生物股份(600201)将召开2025年Q3业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585103541","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585103541?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:25","pubTimestamp":1763835913,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,生物股份报收于11.76元,较上周的11.93元下跌1.42%。本周,生物股份11月20日盘中最高价报12.45元,股价触及近一年最高点。公司公告汇总生物股份关于召开2025年第三季度业绩说明会的公告金宇生物技术股份有限公司将于2025年11月26日15:00-17:00通过上证路演中心举行2025年第三季度业绩说明会,介绍公司2025年第三季度经营成果及财务状况,并与投资者进行互动交流。投资者可于11月19日至11月25日16:00前通过上证路演中心或公司邮箱提交问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0046","BK0028","BK0196","600201","BK0239","BK0012","BK0077","BK0188"],"gpt_icon":0},{"id":"2583554267","title":"11月13日生物股份涨9.11%,国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583554267","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583554267?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:25","pubTimestamp":1763022329,"startTime":"0","endTime":"0","summary":"证券之星消息,11月13日生物股份涨9.11%创60日新高,收盘报11.74元,换手率10.37%,成交量115.3万手,成交额13.0亿元。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为60.97亿元,最新净值0.6589,较上一交易日下跌0.63%,近一年上涨8.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300027506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0188","BK0046","600201","516670","BK0196","BK0239","BK0077","BK0012","BK0028"],"gpt_icon":0},{"id":"2583554269","title":"生物股份涨9.11%,中航证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2583554269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583554269?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:25","pubTimestamp":1763022321,"startTime":"0","endTime":"0","summary":"今日生物股份涨9.11%,收盘报11.74元。2025年8月25日,中航证券研究员彭海兰,陈翼发布了对生物股份的研报《非瘟疫苗领先,创新驱动成长》,该研报对生物股份给出“买入”评级。研报中预计公司2025-2027年归母净利润分别为1.61亿元、2.81亿元、4.06亿元,EPS分别为0.15元、0.25元、0.37元,对应25、26、27年PE分别为63.13 、36.30、25.07倍,维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为39.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300027502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600201"],"gpt_icon":0},{"id":"2580847177","title":"太平洋:给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2580847177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580847177?lang=zh_cn&edition=full","pubTime":"2025-11-04 18:39","pubTimestamp":1762252746,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司程晓东,李忠华近期对生物股份进行研究并发布了研究报告《2025年三季报点评:核心单品持续放量,新型疫苗稳步推进》,给予生物股份买入评级。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级4家,增持评级1家;过去90天内机构目标均价为10.0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400032502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","601099"],"gpt_icon":0},{"id":"2580474689","title":"每周股票复盘:生物股份(600201)Q3净利同比增116.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580474689","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580474689?lang=zh_cn&edition=full","pubTime":"2025-11-02 05:52","pubTimestamp":1762033934,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,生物股份报收于10.79元,较上周的10.77元上涨0.19%。本周关注点来自业绩披露要点:生物股份2025年第三季度归母净利润1.01亿元,同比上升116.4%。股本股东变化截至2025年9月30日,生物股份股东户数为4.9万户,较6月30日减少5873户,减幅10.7%。业绩披露要点生物股份2025年三季报显示,主营收入10.42亿元,同比上升7.38%;归母净利润1.61亿元,同比下降4.85%;扣非净利润1.15亿元,同比下降21.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","BK0239","BK0012","600201","BK0188","BK0185","BK0028","BK0046"],"gpt_icon":0},{"id":"2579764454","title":"生物股份(600201)披露股份回购实施结果暨股份变动的公告,10月31日股价上涨1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579764454","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579764454?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:53","pubTimestamp":1761904416,"startTime":"0","endTime":"0","summary":"近日,生物股份发布关于股份回购实施结果暨股份变动的公告。公告显示,金宇生物技术股份有限公司于2024年10月30日审议通过回购股份方案,回购期限为2024年10月30日至2025年10月29日,回购资金总额不低于8,000万元且不超过16,000万元,回购价格上限为9.98元/股,用于员工持股计划或股权激励。回购股份存放于公司回购专用证券账户,拟用于员工持股计划或股权激励,若36个月内未使用完毕,未使用部分将注销。本次回购不影响公司控制权及上市地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100038353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0188","BK0185","BK0196","BK0077","BK0046","600201","BK0239"],"gpt_icon":0},{"id":"2579913977","title":"生物股份(600201)2025年三季报简析:增收不增利,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2579913977","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579913977?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:03","pubTimestamp":1761689033,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期生物股份发布2025年三季报。截至本报告期末,公司营业总收入10.42亿元,同比上升7.38%,归母净利润1.61亿元,同比下降4.85%。本报告期生物股份公司应收账款体量较大,当期应收账款占最新年报归母净利润比达603.77%。去年的净利率为8.3%,算上全部成本后,公司产品或服务的附加值一般。财报体检工具显示:建议关注公司应收账款状况分析师工具显示:证券研究员普遍预期2025年业绩在1.88亿元,每股收益均值在0.17元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900008289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","600201","BK0188","BK0077","BK0012","BK0196","BK0239","BK0046","BK0028"],"gpt_icon":0},{"id":"2578832616","title":"生物股份(600201)9月30日股东户数4.9万户,较上期减少10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578832616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578832616?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:08","pubTimestamp":1761556097,"startTime":"0","endTime":"0","summary":"证券之星消息,近日生物股份披露,截至2025年9月30日公司股东户数为4.9万户,较6月30日减少5873.0户,减幅为10.7%。在动物保健行业个股中,生物股份股东户数高于行业平均水平,截至9月30日,动物保健行业平均股东户数为2.38万户。从股价来看,2025年6月30日至2025年9月30日,生物股份区间涨幅为20.2%,在此期间股东户数减少5873.0户,减幅为10.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700022778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0028","600201","BK0012","BK0239","BK0185","BK0188","BK0077"],"gpt_icon":0},{"id":"2578724690","title":"生物股份(600201.SH)发布前三季度业绩,归母净利润1.61亿元,下降4.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578724690","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578724690?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:01","pubTimestamp":1761552064,"startTime":"0","endTime":"0","summary":"智通财经APP讯,生物股份(600201.SH)发布2025年三季度报告,该公司前三季度营业收入为10.42亿元,同比增长7.38%。归属于上市公司股东的净利润为1.61亿元,同比减少4.85%。归属于上市公司股东的扣除非经常性损益的净利润为1.15亿元,同比减少21.65%。基本每股收益为0.15元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600201"],"gpt_icon":0},{"id":"2576404938","title":"每周股票复盘:生物股份(600201)子公司获牛疫苗新兽药证","url":"https://stock-news.laohu8.com/highlight/detail?id=2576404938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576404938?lang=zh_cn&edition=full","pubTime":"2025-10-19 03:13","pubTimestamp":1760814788,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘,生物股份报收于10.79元,较上周的10.16元上涨6.2%。本周,生物股份10月17日盘中最高价报11.28元,股价触及近一年最高点。该疫苗主要成分为灭活的牛A型产气荚膜梭菌α毒素蛋白,每头份含200μg,用于预防A型产气荚膜梭菌引起的牛猝死症,免疫期5个月。产品需2~8℃保存,有效期18个月,上市前需取得兽药产品批准文号。该产品获批丰富了公司反刍动物疫苗产品线,体现公司在基因工程亚单位疫苗领域的研发实力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","600201","159646","BK0185","BK0028","BK0012","BK0046","BK0196","BK0239"],"gpt_icon":0},{"id":"2575473957","title":"生物股份(600201)披露子公司取得新兽7月16日股价下跌1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575473957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575473957?lang=zh_cn&edition=full","pubTime":"2025-10-16 22:06","pubTimestamp":1760623584,"startTime":"0","endTime":"0","summary":"截至2025年10月16日收盘,生物股份报收于10.82元,较前一交易日下跌1.9%,最新总市值为120.29亿元。近日,生物股份发布公告称,公司全资子公司金宇保灵生物药品有限公司与浙江海隆生物科技股份有限公司共同研制的牛产气荚膜梭菌病(A型)基因工程亚单位疫苗获国家农业农村部批准,并核发新兽药注册证书。上市前需取得兽药产品批准文号。该产品获批丰富了公司反刍动物疫苗产品线,体现了公司在基因工程亚单位疫苗领域的研发实力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101600036848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0046","BK0185","BK0196","600201","BK0239","BK0012","BK0028","BK0188"],"gpt_icon":0},{"id":"2575718050","title":"生物股份(600201.SH):牛产气荚膜梭菌病(A型)基因工程亚单位疫苗取得新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2575718050","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575718050?lang=zh_cn&edition=full","pubTime":"2025-10-16 16:08","pubTimestamp":1760602111,"startTime":"0","endTime":"0","summary":"智通财经APP讯,生物股份(600201.SH)发布公告,根据国家《兽药管理条例》和《兽药注册办法》规定,经国家农业农村部审查,批准公司全资子公司金宇保灵生物药品有限公司(以下简称“金宇保灵”)与其他公司共同研制的牛产气荚膜梭菌病(A型)基因工程亚单位疫苗为新兽药,并核发了《新兽药注册证书》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0028","BK0188","159646","BK0077","BK0012","BK0185","600201","BK0239","BK0196"],"gpt_icon":0},{"id":"2574452004","title":"每周股票复盘:生物股份(600201)累计回购1,571.33万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2574452004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574452004?lang=zh_cn&edition=full","pubTime":"2025-10-12 01:28","pubTimestamp":1760203692,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,生物股份报收于10.16元,较上周的9.64元上涨5.39%。本周,生物股份10月10日盘中最高价报10.5元,股价触及近一年最高点。截至2025年9月30日,公司累计回购股份1,571.33万股,占公司总股本的1.4134%,已支付金额10,848.54万元,实际回购价格区间为6.37元/股至8.97元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","600201","BK0196","BK0012","BK0028","BK0077","BK0185","BK0239","BK0188"],"gpt_icon":0},{"id":"2574128587","title":"新开源:所持永泰生物股份占其比例为1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574128587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574128587?lang=zh_cn&edition=full","pubTime":"2025-10-10 15:45","pubTimestamp":1760082311,"startTime":"0","endTime":"0","summary":"证券之星消息,新开源(300109)10月10日在投资者关系平台上答复投资者关心的问题。投资者提问:最近港股永泰生物股价低迷,新药即将获批,1、公司是否已增持永泰生物股票,2、目前永泰生物公告供股计划,建议公司增持永泰生物股票,增加永泰生物供股份额新开源回复:您好,谢谢您的建议,截止目前公司所持永泰生物股份占其比例为1.48%,谢谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000020791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","600201","BK0185","BK0229","BK0028","BK0012","BK0046","BK0042","BK0196","BK0239","300109"],"gpt_icon":0},{"id":"2574401166","title":"生物股份(600201)披露以集中竞价交易方式回购公司股份的进展公告,10月09日股价上涨0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574401166","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574401166?lang=zh_cn&edition=full","pubTime":"2025-10-09 22:36","pubTimestamp":1760020580,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘,生物股份报收于9.73元,较前一交易日上涨0.93%,最新总市值为108.17亿元。近日,生物股份发布关于以集中竞价交易方式回购公司股份的进展公告。上述回购进展符合相关规定及方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0028","600201","BK0012","BK0239","BK0185","BK0188","BK0077"],"gpt_icon":0},{"id":"2570602741","title":"异动快报:生物股份(600201)9月26日11点0分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2570602741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570602741?lang=zh_cn&edition=full","pubTime":"2025-09-26 11:00","pubTimestamp":1758855654,"startTime":"0","endTime":"0","summary":"证券之星9月26日盘中消息,11点0分生物股份触及涨停板。目前价格9.58,上涨9.99%。其所属行业动物保健目前上涨。该股为动物保健,内蒙古概念,禽流感概念热股,当日动物保健概念上涨1.15%,内蒙古概念概念上涨1.13%,禽流感概念上涨0.78%。9月25日的资金流向数据方面,主力资金净流出3995.23万元,占总成交额21.21%,游资资金净流入2146.6万元,占总成交额11.4%,散户资金净流入1848.63万元,占总成交额9.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600012522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0185","600201","BK0012","BK0046","BK0196","BK0028","BK0077","BK0188"],"gpt_icon":0},{"id":"2569243784","title":"每周股票复盘:生物股份(600201)将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2569243784","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569243784?lang=zh_cn&edition=full","pubTime":"2025-09-21 02:32","pubTimestamp":1758393134,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:生物股份将于2025年09月23日召开2025年半年度业绩说明会,投资者可提前提交问题。公司公告汇总生物股份关于召开2025年半年度业绩说明会的公告金宇生物技术股份有限公司将于2025年09月23日(星期二)15:00-17:00通过上海证券交易所上证路演中心召开2025年半年度业绩说明会,以视频直播和网络互动方式举行。说明会结束后,投资者可通过上证路演中心查看会议情况及主要内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0012","BK0196","BK0239","BK0028","BK0046","600201","BK0185","BK0188"],"gpt_icon":0},{"id":"2567903361","title":"生物股份(600201)披露召开2025年半年度业绩说明会公告,9月15日股价上涨7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567903361","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567903361?lang=zh_cn&edition=full","pubTime":"2025-09-15 17:26","pubTimestamp":1757928386,"startTime":"0","endTime":"0","summary":"截至2025年9月15日收盘,生物股份报收于8.82元,较前一交易日上涨7.17%,最新总市值为98.06亿元。近日,生物股份发布关于召开2025年半年度业绩说明会的公告。公告显示,金宇生物技术股份有限公司将于2025年09月23日(星期二)15:00-17:00通过上海证券交易所上证路演中心召开2025年半年度业绩说明会,以视频直播和网络互动方式举行。说明会结束后,投资者可通过上证路演中心查看会议情况及主要内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500022663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0046","BK0028","BK0196","600201","BK0239","BK0012","BK0077","BK0188"],"gpt_icon":0},{"id":"2567948851","title":"9月15日生物股份涨7.17%,国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2567948851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567948851?lang=zh_cn&edition=full","pubTime":"2025-09-15 16:23","pubTimestamp":1757924586,"startTime":"0","endTime":"0","summary":"证券之星消息,9月15日生物股份涨7.17%,收盘报8.82元,换手率5.61%,成交量62.41万手,成交额5.39亿元。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为35.74亿元,最新净值0.6732,较上一交易日下跌0.43%,近一年上涨37.08%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500020478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["516670","BK0028","BK0012","BK0196","BK0185","600201","BK0188","BK0046","BK0077","BK0239"],"gpt_icon":0},{"id":"2567194883","title":"生物股份涨7.17%,中航证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2567194883","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567194883?lang=zh_cn&edition=full","pubTime":"2025-09-15 16:22","pubTimestamp":1757924579,"startTime":"0","endTime":"0","summary":"今日生物股份涨7.17%,收盘报8.82元。2025年8月25日,中航证券研究员彭海兰,陈翼发布了对生物股份的研报《非瘟疫苗领先,创新驱动成长》,该研报对生物股份给出“买入”评级。研报中预计公司2025-2027年归母净利润分别为1.61亿元、2.81亿元、4.06亿元,EPS分别为0.15元、0.25元、0.37元,对应25、26、27年PE分别为63.13 、36.30、25.07倍,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中金公司的樊俊豪。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500020475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765151926342,"stockEarnings":[{"period":"1week","weight":0.0966},{"period":"1month","weight":0.3035},{"period":"3month","weight":0.6401},{"period":"6month","weight":0.8249},{"period":"1year","weight":0.9463},{"period":"ytd","weight":0.9605}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金宇生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49033人(较上一季度减少10.70%)","perCapita":"22673股","listingDate":"1999-01-15","address":"内蒙古自治区呼和浩特市土默特左旗经济技术开发区沙尔沁工业园区金宇大街1号","registeredCapital":"111174万元","survey":" 金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。","listedPrice":6.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物股份,600201,生物股份股票,生物股份股票老虎,生物股份股票老虎国际,生物股份行情,生物股份股票行情,生物股份股价,生物股份股市,生物股份股票价格,生物股份股票交易,生物股份股票购买,生物股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}